MARCHESINI, EMANUELA
 Distribuzione geografica
Continente #
NA - Nord America 396
EU - Europa 290
AS - Asia 111
OC - Oceania 1
Totale 798
Nazione #
US - Stati Uniti d'America 379
IE - Irlanda 108
IT - Italia 66
HK - Hong Kong 54
VN - Vietnam 42
UA - Ucraina 32
FI - Finlandia 17
CA - Canada 15
RO - Romania 15
RU - Federazione Russa 13
DE - Germania 12
SE - Svezia 12
CN - Cina 9
GB - Regno Unito 4
AT - Austria 3
TR - Turchia 3
FR - Francia 2
NL - Olanda 2
AU - Australia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
GL - Groenlandia 1
LB - Libano 1
MX - Messico 1
PK - Pakistan 1
PL - Polonia 1
RS - Serbia 1
UZ - Uzbekistan 1
Totale 798
Città #
Dublin 108
Chandler 89
Hong Kong 54
Dong Ket 42
San Mateo 36
Perugia 29
Jacksonville 21
Altamura 17
Medford 15
Ottawa 15
Princeton 15
Bucharest 14
Des Moines 12
Lawrence 10
Andover 9
Beijing 9
Wilmington 9
Santa Clara 8
Falls Church 7
Helsinki 7
Dearborn 5
Saint Petersburg 5
New York 4
Norwalk 4
Buffalo 3
Izmir 3
Redwood City 3
Secaucus 3
Ann Arbor 2
Ashburn 2
Newark 2
Pasadena 2
Redmond 2
San Paolo di Civitate 2
Simi Valley 2
Amsterdam 1
Boardman 1
Boydton 1
Bragadiru 1
Chicago 1
Corciano 1
Den Haag 1
Falkenstein 1
Figline Valdarno 1
Frankfurt Am Main 1
Hanover 1
Houston 1
Lausanne 1
Melbourne 1
Moscow 1
Narni 1
Nuuk 1
Saint Louis 1
San Diego 1
Temecula 1
Vienna 1
Totale 591
Nome #
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 87
Audit clinico sull’impiego di plasma fresco congelato (PFC) in Umbria: disegno dello studio e risultati preliminari. 62
Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management 62
Audit of the clinical use of fresh-frozen plasma in umbria: study design and results. 59
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 50
Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with Haemophilia A and inhibitors. 50
The good use of plasma. A critical analysis of five international guidelines. 47
Clinical audit of the use of fresh frozen plasma in Umbria: study design and results of the pilot phase. 44
Pharmacokinetics of plasma-derived vs. recombinant FVIII concentrates: a comparative study. 44
Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age-matched controls 44
Use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life: comparison with phase III trials 43
Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study 39
Utilizzo di AGREE per l’analisi delle linee guida (LG) internazionali sul buon uso del plasma. 37
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 36
Real-life use of non-vitamin K antagonist oral anticoagulants in comparison with vitamin K antagonists for non-valvular atrial fibrillation: data from a prospective cohort 28
Comorbidities in persons with haemophilia aged 60 years or more compared with age-matched people from the general population 24
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients 21
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 21
Pattern of in-hospital changes in drug use in the older people from 2010 to 2016 19
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 19
Totale 836
Categoria #
all - tutte 3.225
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.225


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 3 0 4 2
2019/202055 0 0 6 0 6 4 5 15 8 9 1 1
2020/2021123 0 4 0 4 34 4 12 3 8 4 7 43
2021/2022155 1 25 1 2 10 2 5 41 3 10 21 34
2022/2023330 15 48 6 20 20 38 22 11 126 4 18 2
2023/2024121 12 18 15 8 4 4 48 1 11 0 0 0
Totale 836